Confluence Investment Management LLC Novo Nordisk A S Transaction History

Confluence Investment Management LLC

  • $6.92 Billion
  • Q4 2024

A detailed history of Confluence Investment Management LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Confluence Investment Management LLC holds 10,274 shares of NVO stock, worth $773,940. This represents 0.01% of its overall portfolio holdings.

Number of Shares
10,274
Previous 10,054 2.19%
Holding current value
$773,940
Previous $1.2 Million 26.23%
% of portfolio
0.01%
Previous 0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 02, 2025
BUY
$85.0 - $120.04 $18,700 - $26,408
220 Added 2.19%
10,274 $883,000
Q3 2024

Oct 31, 2024
SELL
$119.07 - $145.42 $144,074 - $175,958
-1,210 Reduced 10.74%
10,054 $1.2 Million
Q2 2024

Jul 01, 2024
BUY
$122.71 - $146.91 $51,538 - $61,702
420 Added 3.87%
11,264 $1.61 Million
Q1 2024

Apr 01, 2024
SELL
$102.11 - $135.92 $80,258 - $106,833
-786 Reduced 6.76%
10,844 $1.39 Million
Q4 2023

Nov 05, 2024
BUY
$87.78 - $105.45 $75,666 - $90,897
862 Added 8.57%
10,916 $1.13 Million
Q3 2023

Oct 10, 2023
BUY
$90.94 - $199.54 $357,667 - $784,790
3,933 Added 51.1%
11,630 $1.06 Million
Q2 2023

Jul 03, 2023
SELL
$155.98 - $172.65 $148,181 - $164,017
-950 Reduced 10.99%
7,697 $1.25 Million
Q1 2023

Apr 04, 2023
BUY
$132.34 - $159.14 $5,822 - $7,002
44 Added 0.51%
8,647 $1.38 Million
Q4 2022

Jan 03, 2023
SELL
$102.55 - $135.33 $17,228 - $22,735
-168 Reduced 1.92%
8,603 $1.16 Million
Q3 2022

Oct 03, 2022
SELL
$95.28 - $116.93 $74,699 - $91,673
-784 Reduced 8.21%
8,771 $874,000
Q2 2022

Jul 12, 2022
SELL
$103.24 - $121.81 $431,233 - $508,800
-4,177 Reduced 30.42%
9,555 $1.07 Million
Q1 2022

Apr 04, 2022
SELL
$93.1 - $112.54 $177,727 - $214,838
-1,909 Reduced 12.21%
13,732 $1.53 Million
Q4 2021

Jan 04, 2022
SELL
$95.88 - $117.08 $104,605 - $127,734
-1,091 Reduced 6.52%
15,641 $1.75 Million
Q3 2021

Oct 04, 2021
BUY
$84.42 - $106.62 $15,533 - $19,618
184 Added 1.11%
16,732 $1.61 Million
Q2 2021

Jul 01, 2021
BUY
$67.66 - $84.76 $14,479 - $18,138
214 Added 1.31%
16,548 $1.39 Million
Q1 2021

Apr 05, 2021
BUY
$67.06 - $75.82 $71,016 - $80,293
1,059 Added 6.93%
16,334 $1.1 Million
Q4 2020

Jan 25, 2021
SELL
$63.89 - $73.8 $376,951 - $435,420
-5,900 Reduced 27.86%
15,275 $1.07 Million
Q3 2020

Oct 19, 2020
SELL
$63.69 - $70.22 $57,066 - $62,917
-896 Reduced 4.06%
21,175 $1.47 Million
Q2 2020

Jul 01, 2020
SELL
$58.54 - $67.94 $1,346 - $1,562
-23 Reduced 0.1%
22,071 $1.45 Million
Q1 2020

Apr 08, 2020
BUY
$49.46 - $64.78 $1.09 Million - $1.43 Million
22,094 New
22,094 $1.33 Million

Others Institutions Holding NVO

# of Institutions
1,886
Shares Held
335M
Call Options Held
11.9M
Put Options Held
10.6M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $170B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Confluence Investment Management LLC Portfolio

Follow Confluence Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Confluence Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Confluence Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email